D2M INNOVATION LIMITED

Company number 07405791 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: D2M Innovation Limited

1. Financial Health Score: C+

Explanation: The patient is in stable but guarded condition — recovering from a significant financial illness in 2022 but not yet returned to full strength. The business shows encouraging vital signs with improving profitability and a strengthening cash position, but remains heavily reliant on creditor financing, leaving it vulnerable to external shocks. Think of this as a patient who has successfully come off the critical list but still requires careful monitoring and lifestyle changes before being discharged.


2. Key Vital Signs

Heart Rate — Liquidity Health

Metric 2025 2024 Assessment
Current Ratio 1.19x 1.01x ⚠️ Adequate but tight
Cash Ratio 0.69x 0.60x ⚠️ Moderate improvement
Net Current Assets £24,608 £1,047 ✅ Significant improvement

Interpretation: The current ratio has improved from a dangerously thin 1.01x to 1.19x — meaning for every £1 of short-term debts, the company has £1.19 of short-term assets. This is like having just enough oxygen while exercising — functional but no buffer for unexpected exertion. The jump in net current assets from £1,047 to £24,608 is the most encouraging sign here, moving from near-zero working capital to a meaningful cushion.

Blood Pressure — Solvency & Leverage

Metric 2025 2024 Assessment
Net Assets £32,026 £11,475 ✅ Strong recovery
Debt-to-Equity Ratio 4.05x 12.33x ⚠️ Improving but still elevated
Equity as % of Total Assets 19.6% 7.5% ⚠️ Improving from weak base

Interpretation: The debt-to-equity ratio has improved dramatically from 12.33x to 4.05x — this is like a patient whose blood pressure has come down from hypertensive crisis to "stage 1 hypertension." Better, but still requiring treatment. The company remains heavily dependent on creditor financing, with nearly 80% of assets funded by liabilities rather than equity.

Body Temperature — Profitability Trend

Metric 2025 2024 Assessment
P&L Reserve Movement +£20,551 ✅ Healthy profit generated
Net Asset Growth +180% ✅ Strong recovery
Retained Earnings £31,906 £11,355 ✅ Positive trajectory

Interpretation: The P&L reserve grew by approximately £20,551, indicating a profitable year. This is the financial equivalent of a fever breaking — the business is generating positive returns again after the distress of 2022.

Respiratory Function — Cash Flow Health

Metric 2025 2024 2023 2022
Cash at Bank £89,632 £84,944 £102,215 £15,009
Cash as % of Current Liabilities 69% 60% 65% 11%

Interpretation: Cash levels remain healthy at £89,632, covering 69% of current liabilities. The 2022 cash position of just £15,009 was the financial equivalent of shallow, laboured breathing — the company has since restored healthy respiratory function. However, cash has declined from the 2023 peak of £102,215, suggesting some cash consumption.


3. Diagnosis

Primary Condition: Post-Distress Recovery with Residual Vulnerability

The financial data reveals a business that suffered a severe financial episode in FY2022 when net assets fell to negative £17,742 and cash dwindled to just £15,009. This was the equivalent of a cardiac event — the business was technically insolvent on a net assets basis.

Timeline of the Patient's Condition:

Year Net Assets Cash Condition
2020 £115,448 £49,001 🟢 Healthy
2021 £31,231 £78,249 🟡 Moderate — significant equity decline but cash stable
2022 (£17,742) £15,009 🔴 Critical — insolvent, cash depleted
2023 £21,632 £102,215 🟡 Recovering — equity restored, cash rebuilt
2024 £11,475 £84,944 🟡 Setback — equity dipped, cash slightly down
2025 £32,026 £89,632 🟢 Improving — best position since 2021

Symptom Analysis:

1. Structural Weakness — Thin Equity Cushion With only £32,026 in net assets against £129,912 in current liabilities, the equity buffer remains dangerously thin. A £32,000 bad debt or unexpected liability could wipe out the entire net worth. This is the financial equivalent of operating with minimal immune reserves — any infection could become serious.

2. Heavy Creditor Dependence The business operates on what is essentially a "creditor-financed" model. Current liabilities of £129,912 fund the majority of operations. While common in design consultancies, this creates a dependency on supplier goodwill and timely cash collection. If key creditors tighten terms, the working position could deteriorate rapidly.

3. Volatile Earnings Pattern The dramatic swings in net assets (from £115,448 to negative £17,742 and back) suggest a business model with significant revenue or project concentration risk. This volatility is concerning — it suggests the company may be project-dependent with lumpy income streams.

4. Positive Signs — Healing in Progress - Net current assets improved from £1,047 to £24,608 - Cash remains robust at £89,632 - Profitability has returned (P&L reserve growth of £20,551) - Debtors increased from £50,704 to £59,027 (may indicate growing revenue) - Total liabilities reduced by approximately £11,600

5. Minor Concern — Deferred Tax Liability A deferred tax liability of £1,270 has appeared in 2025 (nil in 2024). This is small but worth monitoring — it suggests timing differences in tax treatment, possibly related to capital allowances or accrual adjustments.


4. Recommendations

Immediate Treatment (0-6 months)

1. Build the Equity Cushion The priority should be retaining profits to rebuild equity rather than distributing to shareholders. With only £32,026 in net assets, the target should be to reach at least £50,000-£75,000 before considering any dividend payments. Think of this as building up the patient's strength before resuming normal activities.

2. Debtor Management Protocol Debtors increased by 16.5% (£50,704 to £59,027) — ensure this is not indicative of slowing collections. Implement rigorous credit control: - Review aged debtor reports monthly - Set maximum credit terms of 30 days - Chase overdue invoices within 7 days of due date - Consider invoice financing if working capital pressure increases

3. Creditor Terms Review With £129,912 in current liabilities, negotiate extended payment terms where possible. Even moving from 30-day to 45-day terms with key suppliers would provide meaningful breathing room.

Medium-Term Rehabilitation (6-18 months)

4. Revenue Diversification The historical volatility strongly suggests revenue concentration risk. The business should: - Reduce dependency on any single client or project type - Develop recurring revenue streams (retainer arrangements, licensing) - Build a pipeline that smooths income across quarters

5. Working Capital Targeting Aim to increase the current ratio to at least 1.5x and maintain net current assets above £40,000. This provides a healthy buffer against the type of shock experienced in 2022.

6. Cash Reserve Policy Maintain a minimum cash balance of £50,000 (approximately 5-6 months of operating costs based on the business size). This acts as a financial immune system against unexpected challenges.

Long-Term Wellness (18+ months)

7. Financial Health Monitoring Implement quarterly financial health checks tracking: - Current ratio (target: >1.5x) - Debtor days (target: <35 days) - Net assets trend (target: consistent growth) - Cash as percentage of current liabilities (target: >75%)

8. Consider Capital Restructuring The share capital of just £120 is nominal. If the business continues to recover, consider a formal capitalisation of retained profits through a bonus issue to strengthen the balance sheet's appearance to third parties.

9. Risk Management Given the business operates in "specialised design activities" (SIC 74100) — a sector that can be cyclical and project-dependent — build scenario plans for: - Loss of largest client - Economic downturn reducing design spend - Key personnel risk (family-run business with Staunton family dependence)


Summary Risk Assessment

Risk Category Level Notes
Insolvency Risk 🟡 Medium Positive net assets but thin equity cushion
Liquidity Risk 🟡 Medium Improving but current ratio still below 1.5x
Cash Flow Risk 🟢 Low-Medium Healthy cash balance maintained
Profitability Risk 🟢 Low Profitable and improving
Volatility Risk 🟠 Medium-High History of significant financial swings

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 6 August 2026